AAAAAA
Results:
1-7
|
Results: 7
Authors:
Tavakoli, M
Malek, M
Citation: M. Tavakoli et M. Malek, The cost utility analysis of riluzole for the treatment of amyotrophic lateral sclerosis in the UK, J NEUR SCI, 191(1-2), 2001, pp. 95-102
Authors:
Tavakoli, M
Davies, HTO
Thomson, R
Citation: M. Tavakoli et al., Decision analysis in evidence-based decision making, J EVAL CL P, 6(2), 2000, pp. 111-120
Authors:
Tavakoli, M
Davies, HTO
Thomson, R
Citation: M. Tavakoli et al., Aiding clinical decisions with decision analysis, HOSP MED, 60(6), 1999, pp. 444-447
Authors:
Malek, M
Cunningham-Davis, J
Malek, L
Paschen, B
Tavakoli, M
Zabihollah, M
Davey, P
Citation: M. Malek et al., A cost minimisation analysis of cardiac failure treatment in the UK using CIBIS trial data, INT J CL PR, 53(1), 1999, pp. 19-23
Authors:
Tavakoli, M
Davey, P
Clift, BA
Davies, HTO
Citation: M. Tavakoli et al., Diagnosis and management of osteomyelitis - Decision analytic and pharmacoeconomic considerations, PHARMACOECO, 16(6), 1999, pp. 627-647
Authors:
Tavakoli, M
Prach, AT
Malek, M
Hopwood, D
Senior, BW
Murray, FE
Citation: M. Tavakoli et al., Decision analysis of histamine H-2-receptor antagonist maintenance therapyversus Helicobacter pylori eradication therapy - A randomised controlled trial in patients with continuing pain after duodenal ulcer, PHARMACOECO, 16(4), 1999, pp. 355-365
Authors:
Tavakoli, M
McKiernan, P
Citation: M. Tavakoli et P. Mckiernan, SMEs strategic reaction to the 1992 single market announcement: Evidence from Scottish manufacturing firms, J SM BUS M, 37(1), 1999, pp. 79-89
Risultati:
1-7
|